CCMのチャート
CCMの企業情報
| symbol | CCM |
|---|---|
| 会社名 | Concord Medical Services Holdings Ltd （CONCORD MED SRVS） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | ヘルスケア施設_サ―ビス 医療関連（Health Care） |
| 概要 | コンコルド・メディカル・サービシーズ・ホールディングス（Concord Medical Services Holdings Limited）は中国において放射線治療･画像診断センターによるネットワークを運営する。平成24年12月31日現在、同社のネットワークは中国の24省･行政区の53市の76軒病院に位置する136軒センターから構成される。それらの病院は殆ど衛生部の基準に基づく中国における品質とサイズの最高ランクの病院である3A病院からなる。平成24年6月、同社はCyber MedicalとShanghai Medstarを介してChang''an Hospitalに52%の持分を取得した。平成24年12月、同社は世界のプロトン治療センターであるThe University of Texas MD Anderson Cancer Center Proton Therapy Centerに19.98%の持分を取得した。 コンコ―ド・メディカル・サ―ビシズ・ホ―ルディングスは、中国の持株会社。放射線治療と画像診断機器のリ―スを提供するほか、病院向け管理サ―ビスを手掛ける。中国において、25の行政区内、55都市に位置する81カ所の病院を拠点に全144カ所で放射線治療と画像診断センタ―のネットワ―クを運営する。本社は北京。 Concord Medical Services Holdings Limited is a healthcare provider specializing in cancer care, research and prevention. The Company operates a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centres in China. The Company focuses on providing multidisciplinary cancer care approach in all areas of oncology services in its cancer hospitals. The Company also equips its hospitals with technologically advanced equipment such as the state-of-the-art proton therapy system in its Beijing, Shanghai and Guangzhou cancer hospitals. As of June 30, 2020, the Company operated a network of 27 centers based in 20 hospitals, spanning over 20 cities across 13 provinces and administrative regions in China. To ensure the commitment to the highest level of clinical care for patients, the Company offers ongoing education and training for doctors and other medical professionals in its network hospitals and centres in both local and overseas medical institutions. |
| 本社所在地 | 18/F Tower A Global Trade Center 36 North Third Ring Road East Dongcheng District Beijing 100013 CHN |
| 代表者氏名 | Jianyu Yang |
| 代表者役職名 | Chairman of the Board Chief Executive Officer |
| 電話番号 | +86 10-5825-6867 |
| 設立年月日 | 39387 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 583人 |
| url | www.concordmedical.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | （百万ドル） -27.44857 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | （百万ドル） 130.00870 |
| 売上高 | （百万ドル） 34.21288 |
| 企業価値(EV) | （百万ドル） 164.64685 |
| 当期純利益 | （百万ドル） -46.24259 |
| 決算概要 | BRIEF: For the six months ended 30 June 2018 Concord Medical Services Hldg Ltd (ADR) revenues decreased 49% to RMB105.1M. Net loss increased 26% to RMB128.1M. Revenues reflect Network decrease of 60% to RMB79.4M. Higher net loss reflects Equity pick up of equity investee decrease from RMB4M (income) to RMB3.4M (expense) Loss on disposal of long-lived assets decrease from RMB973K (income) to RMB2.1M (expense). |
CCMのテクニカル分析
CCMのニュース
CrossCountry Mortgage Offers Home Equity Options to Help Homeowners Achieve Financial Goals 2023/01/24 17:38:00 Kwhen Finance
Concord Medical Announces the Successful Holding of the Second Annual Academic Meeting with the world well-known MD Anderson 2022/11/16 12:55:00 PR Newswire
BEIJING, Nov. 16, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an…
Carlisle Companies to Present at Baird Industrial Conference on November 9 2022/11/02 11:31:00 Kwhen Finance
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday 2022/10/11 06:17:36 Benzinga
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN ) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued above the mid-six-figures. Immunic, Inc. (NASDAQ: IMUX ) jumped 56.6% to close at $6.20 after the company announced $60 million oversubscribed private placement equity financing. Green Giant Inc. (NASDAQ: GGE ) gained 39.3% to close at $2.27. Crown ElectroKinetics Corp. (NASDAQ: CRKN ) shares rose 36.2% to close at $0.3540. Dawson James, last month, downgraded Crown ElectroKinetics from Buy to Neutral. Intelligent Living Application Group Inc. (NASDAQ: ILAG ) climbed 29.7% to close at $4.81. Concord Medical Services Holdings Limited (NYSE: CCM ) gained 22.2% to close at $1.65. Universe Pharmaceuticals INC (NASDAQ: UPC ) jumped 22% to settle at $0.85. Stabilis Solutions, Inc. (NASDAQ: SLNG ) rose 21.5% to close at $9.72. Nemaura Medical Inc. (NASDAQ: NMRD ) gained 19.9% to close at $3.13. Recon Technology, Ltd. (NASDAQ: RCON ) gained 19.9% to close at $0.8450.
Concord Medical Services CFO Yaw Kong Yap retires 2022/09/30 20:28:01 Seeking Alpha
Concord Medical Services (CCM) said Friday Yaw Kong Yap retired as CFO and president, effective immediately.Yap will continue to advise CCM going forward.Boxun Zhang, who served as…
AC Power LLC And Solar One Partner to Offer Career Readiness Programs for Students Entering the Solar Energy Sector 2022/06/07 15:54:00 Kwhen Finance
Messagepoint Named a Leader in IDC MarketScape: Worldwide Cloud Customer Communications Management 2022 Vendor Assessment 2022/06/06 14:48:00 Kwhen Finance
Diagnostic Imaging Services Market to grow over US$ 794 Bn by 2030 | MDC Research Study 2022/04/07 13:31:11 Benzinga
Pune, April 07, 2022 (GLOBE NEWSWIRE) -- Diagnostic imaging is a field of medicine that uses non-invasive imaging to diagnose a patient by various imaging procedures. These services include different types of technologies, techniques, and equipment''s that are used to monitor, diagnose, screen, and treat medical conditions and deliver appropriate medical interventions. Diagnostic imaging has improved the ability of doctor''s to treat, diagnose, and detect an injury or disease precisely at an initial stage. Additionally, diagnostic imaging services are can be used to provide relevant information associated with a targeted area of the body that needs to be treated or studied. Diagnostic Imaging Services Market by Region On the basis of region, the global diagnostic imaging market has been segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America holds the major share of the global market. The market in this region is expected to be fuelled by factors such as rising prevalence of chronic diseases, awareness regarding preventative diagnostic imaging and mergers and acquisitions of key service providers of diagnostic imaging coupled with growing number of diagnostic imaging centers.
After 21 Years at Atlantas WFSH, Parks Stamper Retires From Midday Host 2022/02/11 19:00:00 Kwhen Finance
Jason Colodne and Colbeck Capital Support Childrens Cardiomyopathy Foundation 2022/02/09 15:34:00 Kwhen Finance
After 21 Years at Atlantas WFSH, Parks Stamper Retires From Midday Host 2022/02/11 19:00:00 Kwhen Finance
Jason Colodne and Colbeck Capital Support Childrens Cardiomyopathy Foundation 2022/02/09 15:34:00 Kwhen Finance
Concord Medical Services - ADR Shares Close in on 52-Week Low - Market Mover 2022/01/13 05:09:12 Kwhen Finance
Concord Medical Services - ADR (CCM) shares closed today at 1.6% above its 52 week low of $1.85, giving the company a market cap of $0. The stock is currently down 0.3% year-to-date, down 36.3% over the past 12 months, and down 56.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%. Trading Activity Trading volume this week was 62.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -94.7% The company's stock price performance over the past 12 months lags the peer average by -170.7%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.